Assay of environmental toxicants for toxicity related to Alzheimer's Disease utilizing human iPSC-derived- neurons and microglia

Information

  • Research Project
  • 9719451
  • ApplicationId
    9719451
  • Core Project Number
    R44ES026268
  • Full Project Number
    3R44ES026268-02S1
  • Serial Number
    026268
  • FOA Number
    PA-18-591
  • Sub Project Id
  • Project Start Date
    9/1/2018 - 6 years ago
  • Project End Date
    5/31/2020 - 4 years ago
  • Program Officer Name
    SHAUGHNESSY, DANIEL
  • Budget Start Date
    9/1/2018 - 6 years ago
  • Budget End Date
    5/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    02
  • Suffix
    S1
  • Award Notice Date
    8/31/2018 - 6 years ago
Organizations

Assay of environmental toxicants for toxicity related to Alzheimer's Disease utilizing human iPSC-derived- neurons and microglia

This application, submitted in response to solicitation NOT-AG-18-008 AD (?Alzheimer's Disease and its related Dementias (AD/ADRD)-focused Administrative supplements for NIH grants that are not focused on Alzheimer's disease?), is for a supplement to a Phase II SBIR grant (parent project) recently awarded to Vala Sciences Inc (R44ES026268 ?Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons?). The goal of the parent project is to develop assays to test environmental toxicants for toxic effects relevant to Parkinson?s Disease (PD). The supplemental project will develop assays to test environmental agents for toxicity relevant to Alzheimer?s Disease (AD). We will focus on 2.5 micron particles from air pollution (PM2.5) which has been strongly implicated in increasing AD, PD, and Autism Spectrum Disorders (ASD), and the assay system we will develop will feature cortical neurons (glutamatergic = excitatory, and GABAergic = inhibitory) and microglia (MG) derived from human induced pluripotent stem cells (iPSC-glutamatergic neurons and iPSC-MG). MG will be included because neuroinflammation is a key component of AD, PD, and other neurodegenerative/neurodevelopmental diseases. Also, as the epsilon-4 variant of Apolipoprotein E (APOE4, ApoE4) is responsible for the greatest genetic risk of late-onset AD, and likely increases the susceptibility to environmental toxicants, variations of the assay will be developed with neurons and MG representing APOE3/3, APOE3/4, and APOE4/4 genotypes. The supplemental project will greatly increase our understanding of how air pollution increases the prevalence of AD (and also PD) and methods and reagents developed by the supplemental project (improved methods for producing iPSC-MG, and an isogenic iPSC panel representing different APOE genotypes) will have benefits beyond this project, as the basic assay system will potentially be useful in identifying therapeutics against AD, PD, ASD and neuroafflictions such as traumatic brain injury and stroke.

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R44
  • Administering IC
    ES
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    513514
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    113
  • Ed Inst. Type
  • Funding ICs
    NIA:513514\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
  • Study Section Name
  • Organization Name
    VALA SCIENCES, INC.
  • Organization Department
  • Organization DUNS
    612181532
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921213225
  • Organization District
    UNITED STATES